Literature DB >> 21543359

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Panagiota Giakkoupi1, Costas C Papagiannitsis, Vivi Miriagou, Olga Pappa, Michalis Polemis, Kyriaki Tryfinopoulou, Leonidas S Tzouvelekis, Alkiviadis C Vatopoulos.   

Abstract

OBJECTIVES: To follow the epidemic of KPC-2-producing Klebsiella pneumoniae in Greece.
METHODS: KPC-2-producing isolates (n = 378) were collected during January 2009-April 2010 in 40 Greek hospitals. bla(KPC) and bla(VIM) were detected by PCR. Carbapenemase production was confirmed by spectrophotometry. Sequences flanking bla(KPC-2) and their plasmid carriers were studied. Isolates were typed by PFGE and multilocus sequence typing (MLST).
RESULTS: All 378 isolates were bla(KPC-2) positive; 18 also carried bla(VIM-1/VIM-4). Higher isolation frequencies were observed in Athens and Crete. Isolates were classified into 13 PFGE types and 11 sequence types (STs). ST258 was predominant (n = 322), followed by ST147 (n = 20), ST383 (n = 9), ST133 (n = 6), ST274 (n = 4) and ST323 (n = 3). Of the remaining isolates, seven were distributed into five STs (11, 17, 340 and the novel 494 and 495) and seven were not typed. bla(KPC-2) could not be transferred from ST258 isolates, in contrast to isolates of ST17, ST133, ST147, ST274, ST494 and ST495. All bla(KPC-2)-encoding plasmids were of similar size (∼100 kb) and showed indistinguishable restriction fragment length polymorphism (RFLP) patterns except those from the ST340 isolates. Sequences flanking bla(KPC-2) revealed that the Tn4401a isoform was present in plasmids from all STs except ST340 containing Tn4401b. Co-production of VIM enzymes was observed in isolates of ST147, ST323 and ST383.
CONCLUSIONS: Apart from the epidemic of KPC-2-producing K. pneumoniae belonging to ST258 in Greece, diffusion of bla(KPC-2) to at least 10 additional STs has taken place. Notably, strains from three of the latter STs (147, 323 and 383) were found to carry both bla(KPC-2) and bla(VIM).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543359     DOI: 10.1093/jac/dkr166

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  65 in total

1.  Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination.

Authors:  Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Grigorios Xidopoulos; Aris Pliagkos; Vassiliki Chatzipantazi; Fani Markou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

2.  Complete nucleotide sequence of a blaKPC-harboring IncI2 plasmid and its dissemination in New Jersey and New York hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Nahed Al Laham; Roberto G Melano; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

3.  Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone.

Authors:  Dearbháile Morris; Fiona Boyle; Catherine Ludden; Iris Condon; James Hale; Nuala O'Connell; Lorraine Power; Teck Wee Boo; Hiran Dhanji; Christian Lavallee; Neil Woodford; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

4.  Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece.

Authors:  P Bogaerts; R Rezende de Castro; A Deplano; W Bouchahrouf; C Tsobo; O Denis; Y Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.

Authors:  Helen Giamarellou; Lambrini Galani; Fotini Baziaka; Ilias Karaiskos
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

6.  First report of KPC-2 Carbapenemase-producing Klebsiella pneumoniae in Japan.

Authors:  Ryoichi Saito; Rieko Takahashi; Etsuko Sawabe; Saho Koyano; Yutaka Takahashi; Mari Shima; Hiroto Ushizawa; Toshihide Fujie; Naoki Tosaka; Yuko Kato; Kyoji Moriya; Shuji Tohda; Naoko Tojo; Ryuji Koike; Tetsuo Kubota
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 7.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Extended-spectrum β-lactamase CTX-M-15-producing Klebsiella pneumoniae of sequence type ST274 in companion animals.

Authors:  Laurent Poirel; Patrice Nordmann; Sébastien Ducroz; Henri-Jean Boulouis; Pascal Arné; Yves Millemann
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

10.  Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.

Authors:  Christine Lascols; Gisele Peirano; Meredith Hackel; Kevin B Laupland; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.